Science Intelligence and InfoPros

Little things about Scientitic Watch and Information Professionnals

Posts Tagged ‘Roche

Roche and Elsevier alliance to integrate internal data into Reaxys

leave a comment »

Elsevier today announced the integration of Roche propriety reaction information within Reaxys, which will run on Roche’s infrastructure and inside the Roche firewall to provide high performance and security. Roche chemistry information will be securely searchable and discoverable by Roche scientists through the Reaxys user interface. The incorporation and discoverability of Roche proprietary information in Reaxys is anticipated to significantly improve Roche scientists’ productivity.

With this development Roche researchers will be able to launch a single search in Reaxys across integrated internal data and experimental data published in journals and patents, with results unified and organised in a context directly relevant to the researcher workflow. The announcement comes after many months of collaboration between teams from Roche and Reaxys.

Source: STM publishing news, 2nd of October 2012; Available from:


Written by hbasset

October 3, 2012 at 8:39 pm

Posted in Tools

Tagged with , ,

Roche and Pfizer:the first pharma “official pages” on Google+

leave a comment »

According Dominic Tyer.

Pharmaceutical companies have started joining Google’s new social network with Roche and Pfizer the first to set up official Google+ presences.

Fake pages are already an issue on Google+ and Roche’s head of corporate internet and social media Sabine Kostevc explained that one of the reasons she set up Roche’s corporate page was to “reserve the space”.

For now both Roche and Pfizer are only tentatively using Google+, as befits a still emerging social network, but already official pharma pages are outnumbered by fake ones.

Tyer, Dominic. Roche and Pfizer launches pharma’s first official Google+ pages. Digital Intelligence blog, Posted on 6th of December 2011.

Written by hbasset

December 6, 2011 at 9:26 pm

Pharma goes online: 50 apps from top Big Pharmas

leave a comment »

The popularity of smartphones like the iPhone has created an entirely new marketplace for mobile applications.

Pharmaceutical companies are starting to see the value these apps can provide. A properly designed app-be it a medication tracker, a disease calculator, an educational catalogue, or a patient diary-can improve the lives of patients and physicians and thus increase customer collaboration.

At the same time, a well-designed app in the hands of sales reps and marketers can maximize organizational efficiency and create competitive advantage when it comes to selling drugs.

In the past year, pharma investments in smartphone apps, social media platforms, and wireless devices have grown 78 percent

If you go to the Apple App Store today, you’ll find thousands of medical applications; about 50 of these belong to the pharmaceutical industry. Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, and Sanofi-aventis all have apps on the market.

Many of these apps target physicians and nurses:

  • Novartis’ GIST Calculator (Risk of recurrence for Gastrointestinal Stromal Tumors)
  • Roche’s Nursing ACE (educational information for nurses)
  • Johnson & Johnson’s Psoriasis App (calculation of PASI)

or to make the lives of patients better:

  • Merck’s iChemoDiary (record of treatments and medications)
  • Bayer’s Kid-K (gaming for kids with hemophilia)
  • Sanofi-aventis’ GoMeals (nutrition for diabetic population)

When done right, these apps can build a positive association between a brand and a lifestyle and can be integrated into every part of patients’ lives.

Pharma Goes Mobile: Making The Most Of The App Opportunity. Medical News Today, Online, on 24th of March 2011.

Written by hbasset

March 30, 2011 at 7:09 pm

Social Media standard for Big Pharmas

leave a comment »

A good paper I missed in last october:

Roche has moved to master the hazard-prone digital communications space with a new set of internal guidelines on when, where, and how to apply social media tools to communicate with key stakeholders and the public.

The initiative is a novelty for Big Pharma—Roche says it is the first in the industry to go public with a transparent standard for online behavior

The guidance relies on simple “common sense” language, but carves new ground in making explicit the need to:

1) Differentiate between using social media in a personal versus professional context;

2) Build clarity in speaking about the company and on behalf of it, through third parties; and

3) Advocate for employees to serve as “scouts” in tapping networks to identify “sentiment and critical issues.”

The document has been welcomed—if not widely celebrated—by the digital pharma community as a good example of corporate transparency and openness.

Perhaps the most talked about point in the principles is the call for employees to act as scouts.

It is inevitable that other Big Pharma companies will try to build on the document and follow the Roche lead.”

Upton, Julian. Roche sets a New social Media Standard. Pharmaceutical Executive, Online, Oct. 1, 2010.

Written by hbasset

February 17, 2011 at 8:02 pm